News Sentiment

BRTX sentiment intelligence

BioRestorative Therapies Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 56 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.33 Week of 17 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

77/100 classification confidence.

Company focus 47

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-3.2% over one week, -18.4% over four weeks, trend inactive, and below fair value.

Latest direct headline Negative

Leadership shake-up at Biorestorative Therapies (NASDAQ: BRTX) and new CEO

Market Reaction

Balanced read

58/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 77/100 classification
One-week reaction -3.2% Price reacting lower
Trend fit Trend inactive -18.4% over four weeks
Fair value -76.9% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 11
Neutral 36
Negative 9

Relevance

Why the article matched

Direct first
Direct company coverage 47
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
TradingView 14
Market source 12
Stock Titan 10
Moomoo 3
Investing.com 3
Quiver Quantitative 3
simplywall.st 3
GlobeNewswire 2

Event Lens

What the news is about

Classified themes
Market update 26
Earnings 17
Deals and strategy 4
Balance sheet 3
Analyst action 2
Macro sensitivity 2
Regulatory and legal 1
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-56 of 56
TradingView Direct company coverage

Discontinued operations of BioRestorative Therapies, Inc. – DUS:9OF

This article briefly notes the discontinued operations of BioRestorative Therapies, Inc., traded under the ticker DUS:9OF on the Dusseldorf Stock Exchange. It provides context within a financial data platform, indicating the company's market status and the availability of financi

Tone
Negative 35/100
Event
Market update
Published
16 Jun 2026 15:10
Source
TradingView
Investing.com Direct company coverage

BioRestorative Therapies enters $1 million revolving loan and appoints new directors

BioRestorative Therapies (NASDAQ:BRTX) has secured a $1 million revolving loan from Bowery Group LLC for general corporate purposes, despite experiencing negative free cash flow. This financial move coincides with significant leadership changes, including the resignation of three

Tone
Negative 36/100
Event
Balance sheet
Published
12 Jun 2026 21:40
Source
Investing.com
Stock Titan Direct company coverage

BioRestorative (NASDAQ: BRTX) sets 3-year deal with R&D leader Silva

BioRestorative Therapies, Inc. (NASDAQ: BRTX) has signed a new three-year employment agreement with Francisco Silva, its Vice President of Research and Development, effective June 10, 2026. Under the terms, Silva will receive an annual base salary of $575,000, be eligible for a c

Tone
Positive 63/100
Event
Deals and strategy
Published
12 Jun 2026 21:39
Source
Stock Titan